{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:19:12Z","timestamp":1782623952573,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.vaccine.2024.04.092","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T12:21:06Z","timestamp":1714998066000},"page":"3789-3801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Virus-like particle-based multipathogen vaccine of FMD and SVA elicits balanced and broad protective efficacy in mice and pigs"],"prefix":"10.1016","volume":"42","author":[{"given":"Hetao","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahibzada","family":"Waheed Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaozhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huichen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.04.092_b0005","first-page":"9","article-title":"Foot-and-mouth disease: host range and pathogenesis","volume":"288","author":"Alexandersen","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2024.04.092_b0010","doi-asserted-by":"crossref","unstructured":"Dong H, Lu Y, Zhang Y, et al. A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity. J Virol 2021; 95(16):e0017721. doi: 10.1128\/JVI.00177-21. Epub 2021 Jul 26.","DOI":"10.1128\/JVI.00177-21"},{"issue":"7","key":"10.1016\/j.vaccine.2024.04.092_b0015","first-page":"753","article-title":"Foot-and-mouth disease virus and its molecular structure","volume":"62","author":"Paprocka","year":"2006","journal-title":"Med Weter"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.092_b0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/14760584.2021.1877137","article-title":"Challenges in foot-and-mouth disease virus strain selection as an input to attain broad vaccine intraserotype cross-protection","volume":"20","author":"Bergmann","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.04.092_b0025","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3389\/fmicb.2020.01449","article-title":"Adenovirus-vectored capsid proteins of the serotype a foot-and-mouth disease virus protect guinea pigs against challenge","volume":"11","author":"Xie","year":"2020","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2024.04.092_b0030","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1007\/s00253-017-8246-0","article-title":"Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs","volume":"101","author":"Liu","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6563","key":"10.1016\/j.vaccine.2024.04.092_b0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.abd2475","article-title":"Endemic persistence of a highly contagious pathogen: Foot-and-mouth disease in its wildlife host","volume":"374","author":"Jolles","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.04.092_b0040","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3389\/fmicb.2018.00940","article-title":"Review of seneca valley virus: a call for increased surveillance and research","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2024.04.092_b0045","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/tbed.12430","article-title":"Senecavirus A: an emerging vesicular infection in Brazilian Pig Herds","volume":"62","author":"Leme","year":"2015","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2024.04.092_b0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.rvsc.2021.12.010","article-title":"Evaluation of immunogenicity and protective efficacy of a novel Senecavirus A strain-based inactivated vaccine in mice","volume":"142","author":"Li","year":"2021","journal-title":"Res Vet Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.092_b0055","doi-asserted-by":"crossref","first-page":"459","DOI":"10.20506\/rst.10.2.554","article-title":"Viral haemorrhagic disease of rabbits: vaccination and immune response","volume":"10","author":"Villares","year":"1991","journal-title":"Rev Sci Tech"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.092_b0060","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.virol.2007.03.016","article-title":"Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV","volume":"364","author":"Filgueira","year":"2007","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.092_b0065","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.vetmic.2003.09.008","article-title":"Vaccinology of classical swine fever: from lab to field","volume":"96","author":"Oirschot","year":"2003","journal-title":"Vet Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.092_b0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0959-440X(00)00073-7","article-title":"Structures of virus and virus-like particles","volume":"10","author":"Johnson","year":"2000","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.092_b0075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","article-title":"Virus-like particles: passport to immune recognition","volume":"40","author":"Grgacic","year":"2006","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.092_b0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.molimm.2004.06.028","article-title":"Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses","volume":"42","author":"Deml","year":"2005","journal-title":"Mol Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.092_b0085","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/BC.2008.064","article-title":"The coming of age of virus-like particle vaccines","volume":"389","author":"Jennings","year":"2008","journal-title":"Biol Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2024.04.092_b0090","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1586\/14760584.6.3.381","article-title":"Virus-like particles: Flexible platforms for vaccine development","volume":"6","author":"Chackerian","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.092_b0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.092_b0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","article-title":"Major findings and recent advances in virus-like particle (VLP)-based vaccines","volume":"34","author":"Mohsen","year":"2017","journal-title":"Semin Immunol"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2024.04.092_b0105","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0264-410X(98)00421-6","article-title":"The first combined vaccine against hepatitis A and B: an overview","volume":"17","author":"Thoelen","year":"1999","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2024.04.092_b0110","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0264-410X(96)00089-8","article-title":"Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults","volume":"14","author":"Bruguera","year":"1996","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.092_b0115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1297-9716-44-48","article-title":"Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle","volume":"44","author":"Guo","year":"2013","journal-title":"Vet Res"},{"issue":"3","key":"10.1016\/j.vaccine.2024.04.092_b0120","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/vaccines8030532","article-title":"Potent Protective Immune Responses to Senecavirus Induced by Virus-Like Particle Vaccine in Pigs","volume":"8","author":"Mu","year":"2020","journal-title":"Vaccines"},{"issue":"15","key":"10.1016\/j.vaccine.2024.04.092_b0125","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1039\/D1TB02719K","article-title":"Bio-mineralization of virus-like particles by metal-organic framework nanoparticles enhances the thermostability and immune responses of the vaccines","volume":"10","author":"Teng","year":"2022","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.vaccine.2024.04.092_b0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.antiviral.2016.03.005","article-title":"Full protection of swine against foot-and-mouth disease by a bivalent B-cell epitope dendrimer peptide","volume":"129","author":"Blanco","year":"2016","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.092_b0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.vaccine.2018.11.024","article-title":"Interferon gamma (IFN-\u03b3) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens","volume":"37","author":"Nakiboneka","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.092_b0140","unstructured":"Program N. NTP Toxicology and Carcinogenesis Studies of Pyridine (CAS No. 110-86-1) in F344\/N Rats, Wistar Rats, and B6C3F1 Mice (Drinking Water Studies). Natl Toxicol Program Tech Rep Ser 2000; 470: 1-330."},{"key":"10.1016\/j.vaccine.2024.04.092_b0145","first-page":"1","article-title":"Toxicology and carcinogenesis studies of 4-methylimidazole (Cas No. 822\u201336-6) in F344\/N rats and B6C3F1 mice (feed studies)","volume":"535","author":"Program","year":"2007","journal-title":"Natl Toxicol Program tech Rep Ser"},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.092_b0150","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jhep.2020.10.037","article-title":"Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma","volume":"74","author":"Huang","year":"2021","journal-title":"J Hepatol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2024.04.092_b0155","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.vetmic.2007.08.029","article-title":"Foot-and-mouth disease virus infection in young lambs: Pathogenesis and tissue tropism","volume":"127","author":"Ryan","year":"2008","journal-title":"Vet Microbiol"},{"issue":"24","key":"10.1016\/j.vaccine.2024.04.092_b0160","doi-asserted-by":"crossref","first-page":"10415","DOI":"10.1007\/s00253-015-7000-8","article-title":"The application of virus-like particles as vaccines and biological vehicles","volume":"99","author":"Yan","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.092_b0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.22267","article-title":"Acceptable levels of endotoxin in vaccine formulations during preclinical research","volume":"100","author":"Brito","year":"2011","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.092_b0170","doi-asserted-by":"crossref","first-page":"14250","DOI":"10.1038\/s41598-018-32420-3","article-title":"Histopathological changes caused by inflammation and oxidative stress in diet-induced-obese mouse following experimental lung injury","volume":"8","author":"Wang","year":"2019","journal-title":"Sci Rep"},{"issue":"21","key":"10.1016\/j.vaccine.2024.04.092_b0175","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/vr.162.21.690","article-title":"Compatibility between a rabies vaccine and a combined vaccine against feline rhinotracheitis, FCV, FPLV and FeLV, and Chlamydophila felis","volume":"162","author":"Gulot","year":"2008","journal-title":"Vet Rec"},{"issue":"3","key":"10.1016\/j.vaccine.2024.04.092_b0180","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2011.03.005","article-title":"Dengue vaccines: progress and challenges","volume":"23","author":"Coller","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.092_b0185","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/1535370212473703","article-title":"Challenges for the formulation of a universal vaccine against dengue","volume":"238","author":"Chokephaibulkit","year":"2013","journal-title":"Exp Biol Med"},{"issue":"3","key":"10.1016\/j.vaccine.2024.04.092_b0190","first-page":"374","article-title":"Interferon activation and innate immunity","volume":"2","author":"Page","year":"2000","journal-title":"Rev Immunogenet"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.092_b0195","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1615\/CritRevImmunol.2018026790","article-title":"Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells","volume":"38","author":"Bourque","year":"2018","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.04.092_b0200","article-title":"Bi-functional gold Nanocages enhance specific immunological responses of foot-and-mouth disease virus-like particles vaccine as a carrier and adjuvant","volume":"33","author":"Teng","year":"2021","journal-title":"Nanomedicine"},{"issue":"12","key":"10.1016\/j.vaccine.2024.04.092_b0205","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.4049\/jimmunol.168.12.6165","article-title":"Role of IFN-gamma in Th1 differentiation: IFN-gamma regulates IL-18R alpha expression by preventing the negative effects of IL-4 and by inducing\/maintaining IL-12 receptor beta 2 expression","volume":"168","author":"Smeltz","year":"2002","journal-title":"J Immunol"},{"issue":"16","key":"10.1016\/j.vaccine.2024.04.092_b0210","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1073\/pnas.83.16.5894","article-title":"Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities","volume":"83","author":"Yokota","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.092_b0215","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/01926230600867750","article-title":"Histopathology of the Spleen","volume":"34","author":"Suttie","year":"2006","journal-title":"Toxicol Pathol"},{"issue":"6","key":"10.1016\/j.vaccine.2024.04.092_b0220","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ymthe.2005.11.027","article-title":"Cytoglobin overexpression protects against damage-induced fibrosis","volume":"13","author":"Xu","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2024.04.092_b0225","first-page":"159","article-title":"Pathophysiology of pulmonary fibrosis","volume":"259","author":"Crouch","year":"1990","journal-title":"Am J Physiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T11:26:00Z","timestamp":1718018760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":45,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0264410X24005309"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.092","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virus-like particle-based multipathogen vaccine of FMD and SVA elicits balanced and broad protective efficacy in mice and pigs","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}